Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 542395, 10 pages
http://dx.doi.org/10.1155/2014/542395
Research Article

Cytogenetic as an Important Tool for Diagnosis and Prognosis for Patients with Hypocellular Primary Myelodysplastic Syndrome

1Bone Marrow Transplantation Center, National Cancer Institute (INCA), 20230-130 Rio de Janeiro, RJ, Brazil
2Mathematical and Statistical Institute of Federal Fluminense University (UFF), 24020-140 Niterói, RJ, Brazil
3Arthur Siqueira Cavalcanti Hematology Institute (HEMORIO), 20211-030 Rio de Janeiro, RJ, Brazil
4Hematology Service, National Cancer Institute (INCA), 20230-130 Rio de Janeiro, RJ, Brazil
5Pediatric and Puericulture Martagão Gesteira Institute, Federal University of Rio de Janeiro, 21941-590 RJ, Brazil

Received 28 February 2014; Accepted 7 July 2014; Published 11 August 2014

Academic Editor: Emin Karaca

Copyright © 2014 Daiane Corrêa de Souza et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Daiane Corrêa de Souza, Cecília de Souza Fernandez, Adriana Camargo, et al., “Cytogenetic as an Important Tool for Diagnosis and Prognosis for Patients with Hypocellular Primary Myelodysplastic Syndrome,” BioMed Research International, vol. 2014, Article ID 542395, 10 pages, 2014. https://doi.org/10.1155/2014/542395.